Background and aims The performance of neurodegenerative biomarkers-neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), tau, and ubiquitin carboxy-terminal ...
Early use of AHCC during hepatitis stages shows potential to reduce the risk of cirrhosis, according to new research Study: ...
Background and aims Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic ...
A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular ...
New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis ...
A recent Liver International study investigates the effects of stretching and meditation on nocturnal muscle cramps in patients with cirrhosis. ...
This study is led by Dr. Xiaolong Qi (Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, ...
The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% ...
A new research paper was published in Genes & Cancer on February 5, 2023, entitled, "Mechanistically based blood proteomic markers ...
Liver cancer screening among patients with cirrhosis almost doubled when they were mailed a signed order from their specialist, according ...
